IT1212892B - Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica - Google Patents

Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica

Info

Publication number
IT1212892B
IT1212892B IT8349143A IT4914383A IT1212892B IT 1212892 B IT1212892 B IT 1212892B IT 8349143 A IT8349143 A IT 8349143A IT 4914383 A IT4914383 A IT 4914383A IT 1212892 B IT1212892 B IT 1212892B
Authority
IT
Italy
Prior art keywords
hyaluronic acid
therapeutic use
acid obtained
inflammatory activity
molecular filtration
Prior art date
Application number
IT8349143A
Other languages
English (en)
Other versions
IT8349143A0 (it
Inventor
Della Valle Francesco
Romeo Aurelio
Original Assignee
Della Valle Francesco
Romeo Aurelio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11269769&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1212892(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Della Valle Francesco, Romeo Aurelio filed Critical Della Valle Francesco
Priority to IT8349143A priority Critical patent/IT1212892B/it
Publication of IT8349143A0 publication Critical patent/IT8349143A0/it
Priority to FR848415547A priority patent/FR2553099B1/fr
Priority to DE8484306914T priority patent/DE3482812D1/de
Priority to NO844054A priority patent/NO169637C/no
Priority to CH4866/84A priority patent/CH666897A5/fr
Priority to AT84306914T priority patent/ATE54921T1/de
Priority to IN711/CAL/84A priority patent/IN163192B/en
Priority to IE2596/84A priority patent/IE57931B1/en
Priority to IL73217A priority patent/IL73217A/xx
Priority to EP84306914A priority patent/EP0138572B1/en
Priority to DK485384A priority patent/DK171029B1/da
Priority to LU85582A priority patent/LU85582A1/fr
Priority to CA000465231A priority patent/CA1205031A/en
Priority to AR298247A priority patent/AR231992A1/es
Priority to PT79339A priority patent/PT79339B/pt
Priority to KR1019840006280A priority patent/KR860001148B1/ko
Priority to FI843990A priority patent/FI79554C/fi
Priority to ZA847942A priority patent/ZA847942B/xx
Priority to ES536675A priority patent/ES536675A0/es
Priority to HU843811A priority patent/HU195523B/hu
Priority to BE0/213822A priority patent/BE900810A/nl
Priority to AU34148/84A priority patent/AU575861B2/en
Priority to JP59214046A priority patent/JPH068323B2/ja
Publication of IT1212892B publication Critical patent/IT1212892B/it
Application granted granted Critical
Priority to US07/452,681 priority patent/US5166331A/en
Priority to SG594/91A priority patent/SG59491G/en
Priority to HK660/91A priority patent/HK66091A/xx
Priority to US07/931,949 priority patent/US5442053A/en
Priority to US08/426,905 priority patent/US5631241A/en
Priority to US08/471,016 priority patent/US5925626A/en
Priority to JP7211646A priority patent/JP2611159B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
IT8349143A 1982-09-28 1983-10-11 Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica IT1212892B (it)

Priority Applications (30)

Application Number Priority Date Filing Date Title
IT8349143A IT1212892B (it) 1983-10-11 1983-10-11 Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
LU85582A LU85582A1 (fr) 1983-10-11 1984-10-10 Fractions d'acide hyaluronique ayant une activite pharmaceutique,procedes pour leur preparation et compositions pharmaceutiques les contenant
NO844054A NO169637C (no) 1983-10-11 1984-10-10 Fremgangsmaate for fremstilling av terapeutisk aktive hyaluronsyre-fraksjoner
DE8484306914T DE3482812D1 (de) 1983-10-11 1984-10-10 Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
FR848415547A FR2553099B1 (fr) 1983-10-11 1984-10-10 Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
CH4866/84A CH666897A5 (fr) 1983-10-11 1984-10-10 Fractions d'acide hyaluronique non inflammatoire, procedes et compositions pharmaceutiques.
AT84306914T ATE54921T1 (de) 1983-10-11 1984-10-10 Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IN711/CAL/84A IN163192B (it) 1983-10-11 1984-10-10
IE2596/84A IE57931B1 (en) 1983-10-11 1984-10-10 Hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same
IL73217A IL73217A (en) 1983-10-11 1984-10-10 Non-inflammatory hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same
EP84306914A EP0138572B1 (en) 1983-10-11 1984-10-10 Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same
DK485384A DK171029B1 (da) 1983-10-11 1984-10-10 Hyaluronsyrefraktion, fremgangsmåde til fremstilling deraf samt ophthalmiske præparater indeholdende hyaluronsyrefraktion
JP59214046A JPH068323B2 (ja) 1983-10-11 1984-10-11 ヒアルロン酸薬理活性画分、その製造方法および医薬組成物
AU34148/84A AU575861B2 (en) 1983-10-11 1984-10-11 Compositions and extraction of hyaluronic acid
CA000465231A CA1205031A (en) 1983-10-11 1984-10-11 Hyaluronic acid fractions having pharmaceutical activity, and processes for the preparation thereof
PT79339A PT79339B (en) 1983-10-11 1984-10-11 Process for the preparation of hyaluronic acid fractions with pharmaceutical activity
KR1019840006280A KR860001148B1 (ko) 1983-10-11 1984-10-11 약리학적 작용을 가진 히알루론산의 제조방법
FI843990A FI79554C (fi) 1983-10-11 1984-10-11 Foerfarande foer framstaellning av hyaluronsyrafraktioner med farmaceutisk aktivitet.
ZA847942A ZA847942B (en) 1983-10-11 1984-10-11 Hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same
ES536675A ES536675A0 (es) 1983-10-11 1984-10-11 Procedimiento para la fabricacion de fracciones de acido hialuronico
HU843811A HU195523B (en) 1983-10-11 1984-10-11 Process for producing fractions of hyaluronic acid and pharmaceutical compositions containing them
BE0/213822A BE900810A (nl) 1983-10-11 1984-10-11 Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant.
AR298247A AR231992A1 (es) 1983-10-11 1984-10-11 Procedimiento para la fabricacion de fracciones de acido hialuronico
US07/452,681 US5166331A (en) 1983-10-10 1989-12-19 Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
SG594/91A SG59491G (en) 1983-10-11 1991-07-25 Hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same
HK660/91A HK66091A (en) 1983-10-11 1991-08-22 Hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same
US07/931,949 US5442053A (en) 1982-09-28 1992-08-19 Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions
US08/426,905 US5631241A (en) 1983-10-10 1995-04-21 Pharmaceutical compositions containing hyaluronic acid fractions
US08/471,016 US5925626A (en) 1983-10-10 1995-06-06 Hyaluronic acid fractions having pharmaceutical activity, and pharmaceutical compositions containing the same
JP7211646A JP2611159B2 (ja) 1983-10-11 1995-08-21 ヒアルロン酸薬理活性画分、その製造方法および医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8349143A IT1212892B (it) 1983-10-11 1983-10-11 Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica

Publications (2)

Publication Number Publication Date
IT8349143A0 IT8349143A0 (it) 1983-10-11
IT1212892B true IT1212892B (it) 1989-11-30

Family

ID=11269769

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8349143A IT1212892B (it) 1982-09-28 1983-10-11 Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica

Country Status (5)

Country Link
US (1) US5925626A (it)
JP (2) JPH068323B2 (it)
IL (1) IL73217A (it)
IT (1) IT1212892B (it)
ZA (1) ZA847942B (it)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
JPS6084225A (ja) * 1983-10-17 1985-05-13 Hiroko Shimizu 点眼剤
EP0244178A3 (en) * 1986-04-28 1989-02-08 Iolab, Inc Intraocular dosage compositions and method of use
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US5916880A (en) * 1987-12-21 1999-06-29 Bukh Meditec A/S Reduction of skin wrinkling using sulphated sugars
JPH0723317B2 (ja) * 1988-03-17 1995-03-15 生化学工業株式会社 角膜上皮層障害症治療剤
DE3843572A1 (de) * 1988-12-23 1990-06-28 Henkel Kgaa Fliessfaehiges perlglanzkonzentrat
EP0526578A4 (en) * 1990-04-26 1993-09-22 Cytrx Corporation Composition and method for topical treatment of damaged or diseased tissue
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US20110207666A1 (en) * 1996-03-05 2011-08-25 Depuy Spine, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
ITMI20010611A1 (it) * 2001-03-22 2002-09-22 Ibsa Inst Biochimique Sa Cerotto idrocolloidale cicatrizzante contenete acido ialuronico e condroitin solfato
CA2849201A1 (en) 2001-12-07 2003-07-03 Macropore Biosurgery, Inc. Adipose-derived cell processing unit
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
CZ12015U1 (cs) * 2002-01-18 2002-02-25 Cpn Spol. S R.O. Přípravek pro prevenci adheze bandáľe na ránu
KR20050059003A (ko) * 2002-07-02 2005-06-17 프로사이트 코포레이션 펩티드 구리 착화합물 및 연조직 충전제를 함유하는조성물
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US6946551B2 (en) * 2003-03-12 2005-09-20 New Life Resources, Llc Preparation of hyaluronic acid from eggshell membrane
ITMI20032019A1 (it) * 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
US7625581B2 (en) * 2003-12-19 2009-12-01 Ethicon, Inc. Tissue scaffolds for use in muscoloskeletal repairs
US7091191B2 (en) * 2003-12-19 2006-08-15 Ethicon, Inc. Modified hyaluronic acid for use in musculoskeletal tissue repair
FR2865651B1 (fr) * 2004-01-29 2007-09-28 Fabre Pierre Dermo Cosmetique Compositions topiques associant des fragments de hyaluronate de sodium et un retinoide utiles en dermatologie cosmetique et medicale
AU2005213499B2 (en) 2004-02-06 2010-09-02 Georgia Tech Research Corporation Surface directed cellular attachment
AU2005212339B2 (en) 2004-02-06 2010-11-25 Georgia Tech Research Corporation Load bearing biocompatible device
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
WO2006014159A2 (en) * 2004-07-01 2006-02-09 Macropore Biosurgery Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
CA2592044A1 (en) 2004-07-06 2006-02-09 Zymogenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
JP4679138B2 (ja) * 2004-12-24 2011-04-27 株式会社日本バリアフリー 高純度化されたムコ多糖類の製造方法
ITPD20050207A1 (it) * 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US20090163441A1 (en) * 2006-05-11 2009-06-25 Sandra Gobbo Hyaluronic Acid Binary Mixtures and Therapeutic Use Thereof
JP2009541372A (ja) * 2006-06-28 2009-11-26 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ 複数のヒアルロン酸画分を含む化粧用と医療用の組成物
WO2008003321A2 (en) * 2006-07-07 2008-01-10 Novozymes Biopolymer A/S Compositions with several hyaluronic acid fractions for cosmetic use
ITMI20061668A1 (it) * 2006-09-01 2008-03-02 Schiena Michele Giuseppe Di Composizione a base di acido ialuronico e suoi sali per il trattamento di lesioni epiteliali
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
DE102007034639A1 (de) * 2007-07-23 2009-01-29 Antiseptica Chemisch-Pharmazeutische Produkte Gmbh Mehrteiliges Medizinprodukt
WO2010003797A1 (en) * 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
JP5917392B2 (ja) 2009-05-01 2016-05-11 ビミニ テクノロジーズ リミテッド ライアビリティ カンパニー 組織及び細胞富化グラフトを最適化するシステム、方法及び組成物
EP2295076A1 (en) * 2009-09-10 2011-03-16 Biomay Ag Hypoallergenic hybrid polypeptides for the treatment of allergy
ITMI20110033A1 (it) * 2011-01-17 2012-07-18 Biofarmitalia Spa Composizione terapeutica mucoadesiva a base di acido ialuronico per la prevenzione e terapia di lesioni epiteliali, delle mucose del corpo umano
WO2012162552A1 (en) 2011-05-26 2012-11-29 Cartiva, Inc. Tapered joint implant and related tools
KR102032400B1 (ko) * 2011-10-10 2019-10-15 앰피오 파마슈티컬스 인코퍼레이티드 퇴행성 관절 질환의 치료
CN103841934A (zh) 2011-10-10 2014-06-04 安皮奥制药股份有限公司 增强免疫耐受的可植入的医疗装置及其制造与植入方法
RU2477138C1 (ru) * 2011-11-02 2013-03-10 Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия ЛТД" Способ получения заполняющего материала для пластической хирургии и инструментальной косметологии, заполняющий материал и способ введения заполняющего материала в проблемную зону
ITPD20120098A1 (it) 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
ES2627868T3 (es) 2012-10-25 2017-07-31 Mdt Int'l S.A. Composiciones mucoadhesivas que comprenden ácido hialurónico y quitosano para aplicación tópica
EP2910255A1 (en) * 2014-02-19 2015-08-26 MedSkin Solutions Dr. Suwelack AG Methods for the production of biopolymers with defined average molecular weight
FR3020570B1 (fr) * 2014-04-30 2017-07-21 Pierre Fabre Dermo-Cosmetique Association d'un acide hyaluronique et d'un polysaccharide sulfate
EP4066836A1 (en) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
EP3892241A1 (en) 2015-03-31 2021-10-13 Cartiva, Inc. Drill bit for carpometacarpal implant
EP3277219B1 (en) 2015-03-31 2020-07-29 Cartiva, Inc. Hydrogel implants with porous materials
AU2016248062B2 (en) 2015-04-14 2020-01-23 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
JP2018168263A (ja) * 2017-03-29 2018-11-01 日油株式会社 植物性プロテオグリカン及びその用途
GB201713362D0 (en) * 2017-08-21 2017-10-04 Givaudan Sa Improvements in or relating to organic compounds
EP3852725A4 (en) * 2018-09-20 2022-08-03 The Hong Kong University of Science and Technology EYE DROP COMPOSITIONS
WO2023080200A1 (ja) * 2021-11-05 2023-05-11 コスメディ製薬株式会社 眼科用マイクロニードルアレイ

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252264B (de) * 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
US3870791A (en) * 1972-04-24 1975-03-11 Heskel M Haddad Solid state ophthalmic medication delivery method
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4255415A (en) * 1978-11-22 1981-03-10 Schering Corporation Polyvinyl alcohol ophthalmic gel
US4272522A (en) * 1979-10-15 1981-06-09 Balazs Endre A Method for stimulating phagocytic activity and synergistic compositions therefor
IT1141264B (it) * 1980-02-29 1986-10-01 Italfarmaco Spa Processo per la purificazione di glicosaminoglicani
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
DE3172841D1 (en) * 1980-09-29 1985-12-12 Shell Int Research Treatment of pseudoplastic polysaccharide solutions
US4328803B1 (en) * 1980-10-20 1994-01-11 Opthalmic Systems, Inc. Opthalmological procedures
JPS57212108A (en) * 1981-06-17 1982-12-27 Balazs Endre A Hyaluronate composition and cosmetic blend containing same
JPS5856692A (ja) * 1981-09-26 1983-04-04 Shiseido Co Ltd ヒアルロン酸の製造方法
JPS58164601A (ja) * 1982-03-26 1983-09-29 Kohjin Co Ltd 水溶性キトサン塩の製造法
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
JPH068323A (ja) * 1992-06-26 1994-01-18 Asahi Tec Corp 地下管路の補修方法

Also Published As

Publication number Publication date
IT8349143A0 (it) 1983-10-11
US5925626A (en) 1999-07-20
IL73217A (en) 1991-06-30
ZA847942B (en) 1985-05-29
JPH068323B2 (ja) 1994-02-02
JPH08259604A (ja) 1996-10-08
JPS6128503A (ja) 1986-02-08
JP2611159B2 (ja) 1997-05-21

Similar Documents

Publication Publication Date Title
IT1212892B (it) Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
FR2490675B1 (fr) Production microbienne d'interferon de fibroplaste humain
DK536087A (da) Tvaerbundne hyaluronsyreestere
FI901341A0 (fi) Ei-terapeuttisesti käytettävät hyaluronihapon täydelliset ja osittaiset esterit
IT1174547B (it) Procedimento per il trattamento di tele non-tessute e prodotto ottenuto
IT1226905B (it) Composti dell'acido solfonammidotienilcarbossilico
IT8249251A0 (it) Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
IT7869923A0 (it) Granulato di acido silicico precipitate e procedimento per la sua preparazione
IT9022343A0 (it) Dicarbonati e uretani dell'acido 4,5-diidrossi- e 4,5,8-triidrossi- 9,10-diosso-2-antracencarbossilico ad azione terapeutica
BE891610A (fr) Preparation d'anhydrides d'acides carboxyliques
NO844462L (no) Bruk av ultraren hyaluronsyre for aa forbedre dyreleddfunksjoner
DE3478024D1 (de) Amides of 2-phenoxypropionic acid
BE893324A (fr) Preparation d'esters d'acides carboxyliques
BE891611A (fr) Preparation d'anhydrides d'acides carboxyliques
PT87332A (pt) Method of purification of product of expression of recombinant ferment
IT1157325B (it) Esteri dell'acido antranilico
FR2535322B1 (fr) Preparation d'acides aminocyclopentaniques
BE893323A (fr) Preparation d'anhydrides d'acides carboxyliques
IT1222054B (it) Acidi idrossimici di eteri e di tioeteri 7 ossabicicloeptan sostituiti
FR2546514B1 (fr) Procede et systeme pour la production d'ethanol
IT1212000B (it) Fenilbenziliden-derivati dell'acido 3)amminopropansolfonico ad attivita' anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico della epilessia
IT1180215B (it) Acido (2-osso-1-azetidinilossi)-2-propenoico ad attivita' farmaceutica
ITMI920525A1 (it) Derivato dell'acido l-tiazolidin-4-carbossilico, sua preparazione e suo impiego terapeutico
BE894154A (fr) Procede de preparation d'esters des acides alkoxyvincaminiques et alkoxyapovincaminiques
IT1233856B (it) Fluorobenzofenoni e fluorofenilesteri dell'acido fluorobenzoico

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 304; 305; 310; 311

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19981002